About 79% of clinical trial participants experienced measurable improvement after receiving experimental, CRISPR-based gene editing that is designed to fix a rare form of blindness, according to a new article.
Participants of pioneering CRISPR gene editing trial see vision improve
- Post author:
- Post published:May 6, 2024
- Post category:News Feed
- Post comments:0 Comments